table of content
1 Veterinary Biological Vaccines Market Overview
1.1 Product Overview and Scope of Veterinary Biological Vaccines
1.2 Veterinary Biological Vaccines Segment by Type
1.2.1 Global Veterinary Biological Vaccines Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Live Attenuated Vaccines
1.2.3 Inactivated Vaccines
1.2.4 Others
1.3 Veterinary Biological Vaccines Segment by Application
1.3.1 Global Veterinary Biological Vaccines Sales Comparison by Application: (2022-2028)
1.3.2 Livestock
1.3.3 Swine
1.3.4 Chicken
1.3.5 Others
1.4 Global Veterinary Biological Vaccines Market Size Estimates and Forecasts
1.4.1 Global Veterinary Biological Vaccines Revenue 2017-2028
1.4.2 Global Veterinary Biological Vaccines Sales 2017-2028
1.4.3 Veterinary Biological Vaccines Market Size by Region: 2017 Versus 2021 Versus 2028
2 Veterinary Biological Vaccines Market Competition by Manufacturers
2.1 Global Veterinary Biological Vaccines Sales Market Share by Manufacturers (2017-2022)
2.2 Global Veterinary Biological Vaccines Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Veterinary Biological Vaccines Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Veterinary Biological Vaccines Manufacturing Sites, Area Served, Product Type
2.5 Veterinary Biological Vaccines Market Competitive Situation and Trends
2.5.1 Veterinary Biological Vaccines Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Veterinary Biological Vaccines Players Market Share by Revenue
2.5.3 Global Veterinary Biological Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Veterinary Biological Vaccines Retrospective Market Scenario by Region
3.1 Global Veterinary Biological Vaccines Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Veterinary Biological Vaccines Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Veterinary Biological Vaccines Market Facts & Figures by Country
3.3.1 North America Veterinary Biological Vaccines Sales by Country
3.3.2 North America Veterinary Biological Vaccines Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Veterinary Biological Vaccines Market Facts & Figures by Country
3.4.1 Europe Veterinary Biological Vaccines Sales by Country
3.4.2 Europe Veterinary Biological Vaccines Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Veterinary Biological Vaccines Market Facts & Figures by Region
3.5.1 Asia Pacific Veterinary Biological Vaccines Sales by Region
3.5.2 Asia Pacific Veterinary Biological Vaccines Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Veterinary Biological Vaccines Market Facts & Figures by Country
3.6.1 Latin America Veterinary Biological Vaccines Sales by Country
3.6.2 Latin America Veterinary Biological Vaccines Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.6.6 Colombia
3.7 Middle East and Africa Veterinary Biological Vaccines Market Facts & Figures by Country
3.7.1 Middle East and Africa Veterinary Biological Vaccines Sales by Country
3.7.2 Middle East and Africa Veterinary Biological Vaccines Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Veterinary Biological Vaccines Historic Market Analysis by Type
4.1 Global Veterinary Biological Vaccines Sales Market Share by Type (2017-2022)
4.2 Global Veterinary Biological Vaccines Revenue Market Share by Type (2017-2022)
4.3 Global Veterinary Biological Vaccines Price by Type (2017-2022)
5 Global Veterinary Biological Vaccines Historic Market Analysis by Application
5.1 Global Veterinary Biological Vaccines Sales Market Share by Application (2017-2022)
5.2 Global Veterinary Biological Vaccines Revenue Market Share by Application (2017-2022)
5.3 Global Veterinary Biological Vaccines Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Merck Veterinary Biological Vaccines Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Zoetis
6.2.1 Zoetis Corporation Information
6.2.2 Zoetis Description and Business Overview
6.2.3 Zoetis Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Zoetis Veterinary Biological Vaccines Product Portfolio
6.2.5 Zoetis Recent Developments/Updates
6.3 Boehringer Ingelheim
6.3.1 Boehringer Ingelheim Corporation Information
6.3.2 Boehringer Ingelheim Description and Business Overview
6.3.3 Boehringer Ingelheim Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Boehringer Ingelheim Veterinary Biological Vaccines Product Portfolio
6.3.5 Boehringer Ingelheim Recent Developments/Updates
6.4 Ceva
6.4.1 Ceva Corporation Information
6.4.2 Ceva Description and Business Overview
6.4.3 Ceva Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Ceva Veterinary Biological Vaccines Product Portfolio
6.4.5 Ceva Recent Developments/Updates
6.5 CAHIC
6.5.1 CAHIC Corporation Information
6.5.2 CAHIC Description and Business Overview
6.5.3 CAHIC Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2017-2022)
6.5.4 CAHIC Veterinary Biological Vaccines Product Portfolio
6.5.5 CAHIC Recent Developments/Updates
6.6 HVRI
6.6.1 HVRI Corporation Information
6.6.2 HVRI Description and Business Overview
6.6.3 HVRI Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2017-2022)
6.6.4 HVRI Veterinary Biological Vaccines Product Portfolio
6.6.5 HVRI Recent Developments/Updates
6.7 Yebio
6.6.1 Yebio Corporation Information
6.6.2 Yebio Description and Business Overview
6.6.3 Yebio Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Yebio Veterinary Biological Vaccines Product Portfolio
6.7.5 Yebio Recent Developments/Updates
6.8 DHN
6.8.1 DHN Corporation Information
6.8.2 DHN Description and Business Overview
6.8.3 DHN Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2017-2022)
6.8.4 DHN Veterinary Biological Vaccines Product Portfolio
6.8.5 DHN Recent Developments/Updates
6.9 WINSUN
6.9.1 WINSUN Corporation Information
6.9.2 WINSUN Description and Business Overview
6.9.3 WINSUN Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2017-2022)
6.9.4 WINSUN Veterinary Biological Vaccines Product Portfolio
6.9.5 WINSUN Recent Developments/Updates
6.10 Elanco
6.10.1 Elanco Corporation Information
6.10.2 Elanco Description and Business Overview
6.10.3 Elanco Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Elanco Veterinary Biological Vaccines Product Portfolio
6.10.5 Elanco Recent Developments/Updates
6.11 Virbac
6.11.1 Virbac Corporation Information
6.11.2 Virbac Veterinary Biological Vaccines Description and Business Overview
6.11.3 Virbac Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2017-2022)
6.11.4 Virbac Veterinary Biological Vaccines Product Portfolio
6.11.5 Virbac Recent Developments/Updates
6.12 CAVAC
6.12.1 CAVAC Corporation Information
6.12.2 CAVAC Veterinary Biological Vaccines Description and Business Overview
6.12.3 CAVAC Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2017-2022)
6.12.4 CAVAC Veterinary Biological Vaccines Product Portfolio
6.12.5 CAVAC Recent Developments/Updates
6.13 Kyoto Biken Laboratories
6.13.1 Kyoto Biken Laboratories Corporation Information
6.13.2 Kyoto Biken Laboratories Veterinary Biological Vaccines Description and Business Overview
6.13.3 Kyoto Biken Laboratories Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2017-2022)
6.13.4 Kyoto Biken Laboratories Veterinary Biological Vaccines Product Portfolio
6.13.5 Kyoto Biken Laboratories Recent Developments/Updates
6.14 FATRO
6.14.1 FATRO Corporation Information
6.14.2 FATRO Veterinary Biological Vaccines Description and Business Overview
6.14.3 FATRO Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2017-2022)
6.14.4 FATRO Veterinary Biological Vaccines Product Portfolio
6.14.5 FATRO Recent Developments/Updates
6.15 Vaksindo
6.15.1 Vaksindo Corporation Information
6.15.2 Vaksindo Veterinary Biological Vaccines Description and Business Overview
6.15.3 Vaksindo Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2017-2022)
6.15.4 Vaksindo Veterinary Biological Vaccines Product Portfolio
6.15.5 Vaksindo Recent Developments/Updates
6.16 Bio-Labs
6.16.1 Bio-Labs Corporation Information
6.16.2 Bio-Labs Veterinary Biological Vaccines Description and Business Overview
6.16.3 Bio-Labs Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2017-2022)
6.16.4 Bio-Labs Veterinary Biological Vaccines Product Portfolio
6.16.5 Bio-Labs Recent Developments/Updates
6.17 Avimex Animal Health
6.17.1 Avimex Animal Health Corporation Information
6.17.2 Avimex Animal Health Veterinary Biological Vaccines Description and Business Overview
6.17.3 Avimex Animal Health Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2017-2022)
6.17.4 Avimex Animal Health Veterinary Biological Vaccines Product Portfolio
6.17.5 Avimex Animal Health Recent Developments/Updates
6.18 MEVAC
6.18.1 MEVAC Corporation Information
6.18.2 MEVAC Veterinary Biological Vaccines Description and Business Overview
6.18.3 MEVAC Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2017-2022)
6.18.4 MEVAC Veterinary Biological Vaccines Product Portfolio
6.18.5 MEVAC Recent Developments/Updates
6.19 Biovac
6.19.1 Biovac Corporation Information
6.19.2 Biovac Veterinary Biological Vaccines Description and Business Overview
6.19.3 Biovac Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2017-2022)
6.19.4 Biovac Veterinary Biological Vaccines Product Portfolio
6.19.5 Biovac Recent Developments/Updates
6.20 Atafen
6.20.1 Atafen Corporation Information
6.20.2 Atafen Veterinary Biological Vaccines Description and Business Overview
6.20.3 Atafen Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2017-2022)
6.20.4 Atafen Veterinary Biological Vaccines Product Portfolio
6.20.5 Atafen Recent Developments/Updates
6.21 Dyntec
6.21.1 Dyntec Corporation Information
6.21.2 Dyntec Veterinary Biological Vaccines Description and Business Overview
6.21.3 Dyntec Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2017-2022)
6.21.4 Dyntec Veterinary Biological Vaccines Product Portfolio
6.21.5 Dyntec Recent Developments/Updates
6.22 Ringpu Biology
6.22.1 Ringpu Biology Corporation Information
6.22.2 Ringpu Biology Veterinary Biological Vaccines Description and Business Overview
6.22.3 Ringpu Biology Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2017-2022)
6.22.4 Ringpu Biology Veterinary Biological Vaccines Product Portfolio
6.22.5 Ringpu Biology Recent Developments/Updates
6.23 Jinyu Bio-technology
6.23.1 Jinyu Bio-technology Corporation Information
6.23.2 Jinyu Bio-technology Veterinary Biological Vaccines Description and Business Overview
6.23.3 Jinyu Bio-technology Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2017-2022)
6.23.4 Jinyu Bio-technology Veterinary Biological Vaccines Product Portfolio
6.23.5 Jinyu Bio-technology Recent Developments/Updates
6.24 Jinhe Biotechnology
6.24.1 Jinhe Biotechnology Corporation Information
6.24.2 Jinhe Biotechnology Veterinary Biological Vaccines Description and Business Overview
6.24.3 Jinhe Biotechnology Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2017-2022)
6.24.4 Jinhe Biotechnology Veterinary Biological Vaccines Product Portfolio
6.24.5 Jinhe Biotechnology Recent Developments/Updates
6.25 China Animal Husbandry Industry
6.25.1 China Animal Husbandry Industry Corporation Information
6.25.2 China Animal Husbandry Industry Veterinary Biological Vaccines Description and Business Overview
6.25.3 China Animal Husbandry Industry Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2017-2022)
6.25.4 China Animal Husbandry Industry Veterinary Biological Vaccines Product Portfolio
6.25.5 China Animal Husbandry Industry Recent Developments/Updates
6.26 Wuhan Keqian Biology
6.26.1 Wuhan Keqian Biology Corporation Information
6.26.2 Wuhan Keqian Biology Veterinary Biological Vaccines Description and Business Overview
6.26.3 Wuhan Keqian Biology Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2017-2022)
6.26.4 Wuhan Keqian Biology Veterinary Biological Vaccines Product Portfolio
6.26.5 Wuhan Keqian Biology Recent Developments/Updates
6.27 Pulike Biological Engineering
6.27.1 Pulike Biological Engineering Corporation Information
6.27.2 Pulike Biological Engineering Veterinary Biological Vaccines Description and Business Overview
6.27.3 Pulike Biological Engineering Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2017-2022)
6.27.4 Pulike Biological Engineering Veterinary Biological Vaccines Product Portfolio
6.27.5 Pulike Biological Engineering Recent Developments/Updates
6.28 Chengdu Kanghua Biological Products
6.28.1 Chengdu Kanghua Biological Products Corporation Information
6.28.2 Chengdu Kanghua Biological Products Veterinary Biological Vaccines Description and Business Overview
6.28.3 Chengdu Kanghua Biological Products Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2017-2022)
6.28.4 Chengdu Kanghua Biological Products Veterinary Biological Vaccines Product Portfolio
6.28.5 Chengdu Kanghua Biological Products Recent Developments/Updates
7 Veterinary Biological Vaccines Manufacturing Cost Analysis
7.1 Veterinary Biological Vaccines Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Veterinary Biological Vaccines
7.4 Veterinary Biological Vaccines Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Veterinary Biological Vaccines Distributors List
8.3 Veterinary Biological Vaccines Customers
9 Veterinary Biological Vaccines Market Dynamics
9.1 Veterinary Biological Vaccines Industry Trends
9.2 Veterinary Biological Vaccines Market Drivers
9.3 Veterinary Biological Vaccines Market Challenges
9.4 Veterinary Biological Vaccines Market Restraints
10 Global Market Forecast
10.1 Veterinary Biological Vaccines Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Veterinary Biological Vaccines by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Veterinary Biological Vaccines by Type (2023-2028)
10.2 Veterinary Biological Vaccines Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Veterinary Biological Vaccines by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Veterinary Biological Vaccines by Application (2023-2028)
10.3 Veterinary Biological Vaccines Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Veterinary Biological Vaccines by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Veterinary Biological Vaccines by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
